What question did this study set out to answer?

The study aims to assess how different PRS construction methods affect cancer risk prediction across diverse cohorts.

April 5, 2026Cancer Research

Characterizing Polygenic Risk Scores for Cancer in Diverse Prospective Cohorts

Q: What is the clinical evidence from this study?

Study design: Cohort. Population: Cancer (breast, prostate, colorectal, and lung) (n=1064948). Intervention: Polygenic risk scores (PRS-CSx, Lassosum, mJAM, standard GWAS weights) vs. Comparison between PRS weighting strategies. Primary outcome: PRS performance for disease risk prediction.

View Full Paper

Ask AI

Bookmark

Key result

Choice of PRS construction method and cohort characteristics substantially influences major cancer risk prediction.

n=1,064,948

Why the study?

Application of polygenic risk scores and non-genetic factors for personalized disease risk prediction can vary depending on cohort-specific characteristics.

Does the choice of polygenic risk score construction method affect risk prediction performance for major cancers across diverse prospective cohorts?

Population

Over a million subjects across eight large prospective cohorts

Comparison

Four PRS weighting strategies: PRS-CSx, Lassosum, mJAM forward selection, and standard GWAS derived weights

Design

Multi-cohort prospective study

Authors

JDJulie‐Alexia DiasBrigham and Women's Hospital GKGillian KingUniversity of Southern California DBDavid BogumilUniversity of Southern California

Discussion

Member takes

Implication

Clinicians should exercise caution applying PRS for cancer risk across methods and cohorts; leaves open optimal construction strategies for diverse populations.

Key Points

The study aims to assess how different PRS construction methods affect cancer risk prediction across diverse cohorts.
Compared four PRS weighting strategies across eight large prospective cohorts.
Evaluated PRS performance for breast, prostate, colorectal, and lung cancers.
Included various demographic factors like genetic ancestry and age of diagnosis.
Analyzed over a million subjects with diverse racial and ethnic backgrounds.
Demonstrated significant variation in PRS effectiveness based on the chosen weighting method.
Found that cohort characteristics substantially influenced disease risk assessment.
Integrated multiple PRS approaches to enhance understanding of genetic and non-genetic factors in cancer risk.

Study Design

Type

Cohort (n=1,064,948)

Multicenter

Yes

Structured PICO

Does the choice of polygenic risk score construction method affect risk prediction performance for major cancers across diverse prospective cohorts?

Population

Over a million subjects from eight large, prospective cohorts (MEC n=73,139, GERA n=103,358, WHI n=46,794, NHS n=20,195, NHS2 n=16,082, HPFS n=12,649, UKB n=474,775, AoU n=317,956) spanning multiple racial and ethnic groups and broad age distributions.

Intervention

Four polygenic risk score (PRS) weighting strategies: PRS-CSx, Lassosum, multi-ethnic joint analysis of marginal summary statistics (mJAM) forward selection procedure, and standard GWAS derived weights.

Comparator

Comparison among the four PRS weighting strategies.

Outcome

PRS performance for four major cancers (breast, prostate, colorectal, and lung).

The choice of polygenic risk score construction method and target cohort characteristics significantly impact cancer risk prediction performance.

Cite This Study

Dias et al. (2026) conducted a cohort in Cancer (breast, prostate, colorectal, and lung) (n=1,064,948). Polygenic risk scores (PRS-CSx, Lassosum, mJAM, standard GWAS weights) vs. Comparison between PRS weighting strategies was evaluated on PRS performance for disease risk prediction. The choice of polygenic risk score construction method and target cohort characteristics substantially influenced disease risk characterization for four major cancers across over a million subjects.

synapsesocial.com/papers/69d1fdf7a79560c99a0a464e https://doi.org/10.1158/1538-7445.am2026-3584

View Full Paper

Ask AI

Bookmark

Implication

Clinicians should exercise caution applying PRS for cancer risk across methods and cohorts; leaves open optimal construction strategies for diverse populations.

Characterizing Polygenic Risk Scores for Cancer in Diverse Prospective Cohorts

Discussion

Member takes

Implication

Key Points

Study Design

Structured PICO

Cite This Study

Characterizing Polygenic Risk Scores for Cancer in Diverse Prospective Cohorts

Discussion

Member takes

Implication

Key Points

Study Design

Structured PICO

Cite This Study

Also Consider

Also Consider